AWARDBPA CALLOther than small business
BPA call 75F40122F19002ACCENTURE FEDERAL SERVICES LLC
Overview
Award facts
- Net obligations
- $6.48M
- $6,476,689of $6.48M potential value
- Outlays (paid to date)
- $6.48M
- $6.48M paid of $6.48M obligated$6,476,689
- Period of performance
- Aug 9, 2022 to Aug 9, 2024
- Ended
- Modifications
- 2
- Latest action Mar 11, 2025
- Contract type
- BPA call
- PIID 75F40122F19002
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
SCIENTIFIC AND OPERATIONAL SUPPORT FOR CDER.
Dates and value
- Award date
- Signed on Aug 9, 2022
- Potential end of performance
- Aug 8, 2024
- Current value
- $6,476,689Base and exercised options
- Potential value (if all options are exercised)
- $6,476,689
- Parent contract vehicle
- 75F40122A00002 (BPA, multiple award) — 4 orders recorded under it
Obligations by fiscal year of action
- FY2025: -$50,934 (de-obligation)
- FY2023: $3,220,592
- FY2022: $3,307,031
Total across 3 fiscal years: $6,476,689
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 11, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEIC47BNA8GM833
CAGE code1ZD18
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyNOVETTA SOLUTIONS, LLC
Business types and certifications
Foreign-ownedFor-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0002
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R699SUPPORT- ADMINISTRATIVE: OTHER (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
- Offers received
- 1
Contract details
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Aug 9, 2022Base obligation at award: $3,307,031
- Latest action
- Mar 11, 2025 — CloseoutModification P00002; obligation change -$50,934; administrative: no change in scope or value
- Latest substantive action
- May 23, 2023 — Option exercisedModification P00001; obligation change +$3,220,592
- Actions by type
- Base award1
- Option exercised1
- Closeout1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$50,934
- Latest action: change in base and all options
- -$3,282,164
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2022/2022-0600-000
- 075-2023/2023-0600-000
- 075-X-0600-000
- Object classes
- 25.3: Other goods and services from Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $413,533
- COVID-19 supplemental outlays
- $413,533